
Intra-Cellular Therapies, Inc.
USD131.87
+0.00 (+0.00%)
CEO
Sharon Mates
IPO Date
2014-01-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$131.87
Prev. Close
$131.87
Day Low
$131.87
Day High
$131.87
52W Low
$64.09
52W High
$131.98
Market Cap
$14.05B
Volume
16.04M
| 31 Jan 2025 |
| Canaccord Genuity |
| Buy |
| Hold |
| downgrade |
| 22 Jan 2025 | RBC Capital | Outperform | Sector Perform | downgrade |
| 14 Jan 2025 | Piper Sandler | Overweight | Neutral | downgrade |
| 13 Jan 2025 | Needham | Buy | Hold | downgrade |
| 4 Nov 2024 | JP Morgan | Overweight | Overweight | maintain |
| 31 Oct 2024 | Needham | Buy | Buy | maintain |
| 30 Oct 2024 | Needham | Buy | Buy | maintain |